Search

everythinglearnresearchcommunity

for

Search:↓

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Panitumumab can cause excessive ear hair growth.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Some drugs can cause permanent hair loss, though it's rare.

Gray hair can potentially be reversed, leading to new treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

EGFR inhibitors for lung cancer can cause severe skin issues.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Personalized medicine and new technologies offer promising strategies for better skin disease treatments.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Dupilumab can cause psoriasis in some patients.

Denosumab may cause alopecia areata.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

A woman's skin symptoms led to a diagnosis of systemic AL amyloidosis, but she died from sepsis shortly after.

Collagen XVII and CD151 affect cell movement, with CD151 inhibiting migration when bound to integrins.